Science:Life Sciences
The case for precision medicine to treat cancer has been clear. Understanding the molecular underpinnings of a patient’s cancer can allow doctors to use targeted therapies that can best address their particular tumor type. The people behind One Health believe it should be no different for dogs. The company, which bills itself as the world’s first canine cancer care organization, is seeking to bring precision cancer care to our four-legged friends. We spoke to Christina Lopes, founder and CEO of One Health, about the state of canine cancer care, the company’s FidoCure service and the market for state-of-the art medicine for dogs.
view more
More Episodes
A Biopharma Downturn or Return to Trend
2023-04-12
2023-04-12
Forcing Cancers to Reveal Themselves
2023-03-01
2023-03-01
Mining Bugs for Drugs
2023-02-16
2023-02-16
Changing Outcomes with Data
2023-01-25
2023-01-25
The Year in Biotech and What’s Ahead in 2023
2022-12-29
2022-12-29
The Growing Need for Biosecurity Vigilance
2022-12-15
2022-12-15
Get this podcast on your
phone, FREE
